MADRIGAL PHARMACEUTICALS, INC. (MDGL) /
The debt of MADRIGAL PHARMACEUTICALS, INC. over the past 10 years
Chart MADRIGAL PHARMACEUTICALS, INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, MADRIGAL PHARMACEUTICALS, INC. had liquid cash of $983.56M and total debt of $339.88M: net cash of $643.68M. It had more liquid cash than debt at all 9 year-ends shown. Total debt was highest at the end of fiscal 2025 ($339.88M) and lowest at the end of fiscal 2017 ($0).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $983.56M* | $339.88M | $643.68M |
| 2024ended Dec 31, 2024 | $926.25M* | $117.57M | $808.68M |
| 2023ended Dec 31, 2023 | $634.13M* | $115.48M | $518.65M |
| 2022ended Dec 31, 2022 | $358.77M* | $49.29M | $309.49M |
| 2021ended Dec 31, 2021 | $270.35M* | $0 | $270.35M |
| 2020ended Dec 31, 2020 | $284.15M* | $0 | $284.15M |
| 2019ended Dec 31, 2019 | $439.05M* | $0 | $439.05M |
| 2018ended Dec 31, 2018 | $483.72M* | $0 | $483.72M |
| 2017ended Dec 31, 2017 | $191.53M* | $0 | $191.53M |
| 2016ended Dec 31, 2016 | $40.5M* | — | — |
Fiscal years as MADRIGAL PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on MADRIGAL PHARMACEUTICALS, INC.
- The revenue of MADRIGAL PHARMACEUTICALS, INC.
- The profitability of MADRIGAL PHARMACEUTICALS, INC.
- The cash flow of MADRIGAL PHARMACEUTICALS, INC.
- All of MADRIGAL PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- SITMSiTime Corporation
- SWKSSKYWORKS SOLUTIONS, INC.
- BSYBENTLEY SYSTEMS, INCORPORATED
- HCMHutchMED (China) LIMITED
- DTMDT Midstream, Inc.
Not investment advice. This page shows what MADRIGAL PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.